Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Weiss

Showing results (21-30 of 153) with videos related to

Pageof 16
Sort By:
The Medical Clinics of North America|March 1, 1973
Bleeding disorders due to abnormal platelet functionH J Weiss
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
Type 2B von Willebrand disease and related disorders of patients with increased ristocetin-induced platelet aggregation: what they tell us about the role of von Willebrand factor in hemostasisH J Weiss
The New England Journal of Medicine|September 10, 1970
Aspirin, platelets and hemostasisH J Weiss
The New England Journal of Medicine|December 10, 1970
Thromboembolism--a continuing challengeH J Weiss
Lancet (London, England)|May 5, 1973
Low-molecular-weight factor VIIIH J Weiss
Progress in Hemostasis and Thrombosis|January 1, 1972
The pharmacology of platelet inhibitionH J Weiss
American Heart Journal|July 1, 1976
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosisH J Weiss
Seminars in Hematology|October 1, 1994
Scott syndrome: a disorder of platelet coagulant activityH J Weiss
Schweizerische Medizinische Wochenschrift|January 26, 1974
Inhibition of platelet-induced thrombus formationH J Weiss
Annals of the New York Academy of Sciences|October 27, 1972
Abnormalities in platelet function due to defects in the release reactionH J Weiss
Pageof 16

Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
The Medical Clinics of North America|March 1, 1973
Bleeding disorders due to abnormal platelet functionH J Weiss
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
Type 2B von Willebrand disease and related disorders of patients with increased ristocetin-induced platelet aggregation: what they tell us about the role of von Willebrand factor in hemostasisH J Weiss
The New England Journal of Medicine|September 10, 1970
Aspirin, platelets and hemostasisH J Weiss
The New England Journal of Medicine|December 10, 1970
Thromboembolism--a continuing challengeH J Weiss
Lancet (London, England)|May 5, 1973
Low-molecular-weight factor VIIIH J Weiss
Progress in Hemostasis and Thrombosis|January 1, 1972
The pharmacology of platelet inhibitionH J Weiss
American Heart Journal|July 1, 1976
Antiplatelet drugs-a new pharmacologic approach to the prevention of thrombosisH J Weiss
Seminars in Hematology|October 1, 1994
Scott syndrome: a disorder of platelet coagulant activityH J Weiss
Schweizerische Medizinische Wochenschrift|January 26, 1974
Inhibition of platelet-induced thrombus formationH J Weiss
Annals of the New York Academy of Sciences|October 27, 1972
Abnormalities in platelet function due to defects in the release reactionH J Weiss
Pageof 16